Global Nanopharmaceuticals Market Research Report 2019

Table of Contents

Executive Summary

1 Nanopharmaceuticals Market Overview

• 1.1 Product Overview and Scope of Nanopharmaceuticals
• 1.2 Nanopharmaceuticals Segment by Type
  • 1.2.1 Global Nanopharmaceuticals Production Growth Rate Comparison by Type (2014-2025)
  • 1.2.2 Liposomes
  • 1.2.3 Polymeric Micelles
  • 1.2.4 Solid Lipid Nanoparticles
  • 1.2.5 Microemulsion and Nnanoemulsion
  • 1.2.6 Nanosuspension
• 1.3 Nanopharmaceuticals Segment by Application
  • 1.3.1 Nanopharmaceuticals Consumption Comparison by Application (2014-2025)
  • 1.3.2 Cancer and Tumor
  • 1.3.3 Autoimmune Disorders
  • 1.3.4 Inflammation
  • 1.3.5 Others
• 1.3 Global Nanopharmaceuticals Market by Region
  • 1.3.1 Global Nanopharmaceuticals Market Size Region
  • 1.3.2 North America Status and Prospect (2014-2025)
  • 1.3.3 Europe Status and Prospect (2014-2025)
  • 1.3.4 China Status and Prospect (2014-2025)
  • 1.3.5 Japan Status and Prospect (2014-2025)
  • 1.3.6 Southeast Asia Status and Prospect (2014-2025)
  • 1.3.7 India Status and Prospect (2014-2025)
• 1.4 Global Nanopharmaceuticals Market Size
  • 1.4.1 Global Nanopharmaceuticals Revenue (2014-2025)
  • 1.4.2 Global Nanopharmaceuticals Production (2014-2025)

2 Global Nanopharmaceuticals Market Competition by Manufacturers

• 2.1 Global Nanopharmaceuticals Production Market Share by Manufacturers (2014-2019)
• 2.2 Global Nanopharmaceuticals Revenue Share by Manufacturers (2014-2019)
• 2.3 Global Nanopharmaceuticals Average Price by Manufacturers (2014-2019)
• 2.4 Manufacturers Nanopharmaceuticals Production Sites, Area Served, Product Types
• 2.5 Nanopharmaceuticals Market Competitive Situation and Trends
  • 2.5.1 Nanopharmaceuticals Market Concentration Rate
  • 2.5.2 Nanopharmaceuticals Market Share of Top 3 and Top 5 Manufacturers
  • 2.5.3 Mergers & Acquisitions, Expansion

3 Global Nanopharmaceuticals Production Market Share by Regions

• 3.1 Global Nanopharmaceuticals Production Market Share by Regions
• 3.2 Global Nanopharmaceuticals Revenue Market Share by Regions (2014-2019)
• 3.3 Global Nanopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)
• 3.4 North America Nanopharmaceuticals Production
  • 3.4.1 North America Nanopharmaceuticals Production Growth Rate (2014-2019)
  • 3.4.2 North America Nanopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)
• 3.5 Europe Nanopharmaceuticals Production
  • 3.5.1 Europe Nanopharmaceuticals Production Growth Rate (2014-2019)
  • 3.5.2 Europe Nanopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)
• 3.6 China Nanopharmaceuticals Production (2014-2019)
  • 3.6.1 China Nanopharmaceuticals Production Growth Rate (2014-2019)
  • 3.6.2 China Nanopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)
• 3.7 Japan Nanopharmaceuticals Production (2014-2019)
  • 3.7.1 Japan Nanopharmaceuticals Production Growth Rate (2014-2019)
  • 3.7.2 Japan Nanopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Nanopharmaceuticals Consumption by Regions

• 4.1 Global Nanopharmaceuticals Consumption by Regions
• 4.2 North America Nanopharmaceuticals Consumption (2014-2019)
• 4.3 Europe Nanopharmaceuticals Consumption (2014-2019)
• 4.4 China Nanopharmaceuticals Consumption (2014-2019)
• 4.5 Japan Nanopharmaceuticals Consumption (2014-2019)

5 Global Nanopharmaceuticals Production, Revenue, Price Trend by Type

• 5.1 Global Nanopharmaceuticals Production Market Share by Type (2014-2019)
• 5.2 Global Nanopharmaceuticals Revenue Market Share by Type (2014-2019)
• 5.3 Global Nanopharmaceuticals Price by Type (2014-2019)
• 5.4 Global Nanopharmaceuticals Production Growth by Type (2014-2019)

6 Global Nanopharmaceuticals Market Analysis by Applications

• 6.1 Global Nanopharmaceuticals Consumption Market Share by Application (2014-2019)
• 6.2 Global Nanopharmaceuticals Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Nanopharmaceuticals Business

• 7.1 Merck
  • 7.1.1 Merck Nanopharmaceuticals Production Sites and Area Served
  • 7.1.2 Nanopharmaceuticals Product Introduction, Application and Specification
  • 7.1.3 Merck Nanopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.1.4 Main Business and Markets Served
• 7.2 Pfizer
  • 7.2.1 Pfizer Nanopharmaceuticals Production Sites and Area Served
  • 7.2.2 Nanopharmaceuticals Product Introduction, Application and Specification
  • 7.2.3 Pfizer Nanopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.2.4 Main Business and Markets Served
• 7.3 Novartis
  • 7.3.1 Novartis Nanopharmaceuticals Production Sites and Area Served
  • 7.3.2 Nanopharmaceuticals Product Introduction, Application and Specification
  • 7.3.3 Novartis Nanopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.3.4 Main Business and Markets Served
• 7.4 Abbott
  • 7.4.1 Abbott Nanopharmaceuticals Production Sites and Area Served
  • 7.4.2 Nanopharmaceuticals Product Introduction, Application and Specification
  • 7.4.3 Abbott Nanopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.4.4 Main Business and Markets Served
• 7.5 GlaxoSmithKline
  • 7.5.1 GlaxoSmithKline Nanopharmaceuticals Production Sites and Area Served
  • 7.5.2 Nanopharmaceuticals Product Introduction, Application and Specification
  • 7.5.3 GlaxoSmithKline Nanopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.5.4 Main Business and Markets Served
• 7.6 Roche
  • 7.6.1 Roche Nanopharmaceuticals Production Sites and Area Served
  • 7.6.2 Nanopharmaceuticals Product Introduction, Application and Specification
  • 7.6.3 Roche Nanopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.6.4 Main Business and Markets Served
• 7.7 Sanofi
  • 7.7.1 Sanofi Nanopharmaceuticals Production Sites and Area Served
  • 7.7.2 Nanopharmaceuticals Product Introduction, Application and Specification
  • 7.7.3 Sanofi Nanopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.7.4 Main Business and Markets Served
• 7.8 Eli Lilly
  • 7.8.1 Eli Lilly Nanopharmaceuticals Production Sites and Area Served
  • 7.8.2 Nanopharmaceuticals Product Introduction, Application and Specification
  • 7.8.3 Eli Lilly Nanopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.8.4 Main Business and Markets Served
• 7.9 Astrazeneca
  • 7.9.1 Astrazeneca Nanopharmaceuticals Production Sites and Area Served
  • 7.9.2 Nanopharmaceuticals Product Introduction, Application and Specification
  • 7.9.3 Astrazeneca Nanopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.9.4 Main Business and Markets Served
• 7.10 Johnson & Johnson
  • 7.10.1 Johnson & Johnson Nanopharmaceuticals Production Sites and Area Served
  • 7.10.2 Nanopharmaceuticals Product Introduction, Application and Specification
  • 7.10.3 Johnson & Johnson Nanopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.10.4 Main Business and Markets Served
• 7.11 Celgene
• 7.12 Novavax
• 7.13 Stryker
• 7.14 Gilead Sciences
• 7.15 OSI Pharmaceuticals
• 7.16 Kadmon Pharmaceuticals
• 7.17 Samyang Biopharm
• 7.18 Mitsubishi Pharma
• 7.19 Kaken Pharmaceutical
• 7.20 Selecta Biosciences
• 7.21 Par Pharmaceutical
• 7.22 Cerulean Pharma
• 7.23 Navidea Biopharmaceuticals
• 7.24 Lummy

8 Nanopharmaceuticals Manufacturing Cost Analysis

• 8.1 Nanopharmaceuticals Key Raw Materials Analysis
  • 8.1.1 Key Raw Materials
  • 8.1.2 Price Trend of Key Raw Materials
  • 8.1.3 Key Suppliers of Raw Materials
• 8.2 Proportion of Manufacturing Cost Structure
• 8.3 Manufacturing Process Analysis of Nanopharmaceuticals
• 8.4 Nanopharmaceuticals Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

• 9.1 Marketing Channel
  • 9.1.1 Direct Marketing
  • 9.1.2 Indirect Marketing
• 9.2 Nanopharmaceuticals Distributors List
• 9.3 Nanopharmaceuticals Customers

10 Market Dynamics

• 10.1 Market Trends
• 10.2 Opportunities
• 10.3 Market Drivers
• 10.4 Challenges
• 10.5 Influence Factors

11 Global Nanopharmaceuticals Market Forecast

• 11.1 Global Nanopharmaceuticals Production, Revenue Forecast
  • 11.1.1 Global Nanopharmaceuticals Production Growth Rate Forecast (2019-2025)
  • 11.1.2 Global Nanopharmaceuticals Revenue and Growth Rate Forecast (2019-2025)
  • 11.1.3 Global Nanopharmaceuticals Price and Trend Forecast (2019-2025)
• 11.2 Global Nanopharmaceuticals Production Forecast by Regions (2019-2025)
  • 11.2.1 North America Nanopharmaceuticals Production, Revenue Forecast (2019-2025)
  • 11.2.2 Europe Nanopharmaceuticals Production, Revenue Forecast (2019-2025)
  • 11.2.3 China Nanopharmaceuticals Production, Revenue Forecast (2019-2025)
  • 11.2.4 Japan Nanopharmaceuticals Production, Revenue Forecast (2019-2025)
• 11.3 Global Nanopharmaceuticals Consumption Forecast by Regions (2019-2025)
  • 11.3.1 North America Nanopharmaceuticals Consumption Forecast (2019-2025)
  • 11.3.2 Europe Nanopharmaceuticals Consumption Forecast (2019-2025)
  • 11.3.3 China Nanopharmaceuticals Consumption Forecast (2019-2025)
  • 11.3.4 Japan Nanopharmaceuticals Consumption Forecast (2019-2025)
• 11.4 Global Nanopharmaceuticals Production, Revenue and Price Forecast by Type (2019-2025)
• 11.5 Global Nanopharmaceuticals Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List